INSIGHTS ON DRUG DEVELOPMENT

• Integrating High-Content Imaging With Traditional Plate-Based Screening

  Gain mechanistic insights beyond traditional viability assays, revealing nuanced cellular phenotypes and strengthening early drug discovery decisions without sacrificing throughput or efficiency.

• Advancing Drug Development Through Expertise In Energetic Chemistry

  Overcoming development complexity requires robust process safety. Solutions can safely scale challenging reactions, like click chemistry and cryogenic organometallics, improving efficiency and results.

• Overcoming Challenges In Ophthalmic Formulations

  Discover key strategies for overcoming formulation challenges in ophthalmic drug development and learn how selecting the right excipients supports quality, compliance, and safety.

• Generate CHO-K1 GFP-Expressing Cells For Cell Line Development Workflow

  Discover a high-efficiency workflow for generating GFP-expressing CHO-K1 clones using automated single-cell dispensing to achieve 93% isolation success and stable expression in under five weeks.

• High Potency APIs And The Evolving Demands Of Drug Development

  4/13/2026

  See how higher API activity is changing expectations around containment, scalability, and cross‑functional alignment — and why early decisions now have a greater impact on long‑term success.

• Imagine The Future: An Enhanced Oligonucleotide Synthesis Process

  2/9/2026

  Gain practical guidance for improving oligo quality, see how an advanced synthesis platform supports production, and explore a software interface designed to make daily operations more intuitive.

• Transforming A Liquid Protein Solution Into A Solid Oral Dosage Form

  3/4/2025

  Unlocking the potential of oral protein therapeutics requires innovative formulation and manufacturing strategies to overcome stability, absorption, and bioavailability challenges.

• Spray Dried Dispersions In Controlled Release Formulations

  10/16/2025

  Integrating spray dried dispersions with CR strategies addresses poor drug solubility and the need for tailored release kinetics. Explore considerations to ensure stability and sustained supersaturation.

• R&D Excellence at Asymchem's UK Facility

  3/12/2026

  Dave Henderson outlines R&D excellence at a UK facility, highlighting integrated labs, advanced experimentation, expert teams, and seamless progression from discovery through scale-up and manufacturing.